Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, May 3, 2021
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Robert Burns Initiated (VIRX) at Strong Buy and Held Target at $35 on, May 3rd, 2021
Robert Burns of HC Wainwright & Co., Initiated "Viracta Therapeutics, Inc." (VIRX) at Strong Buy and Held Target at $35 on, May 3rd, 2021.
Robert has made no other calls on VIRX in the last 4 months.
There are 2 other peers that have a rating on VIRX. Out of the 2 peers that are also analyzing VIRX, 0 agree with Robert's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Robert
- Andrew Berens of "SVB Leerink" Initiated at Buy and Held Target at $18 on, Monday, April 26th, 2021
- Josh Schimmer of "Evercore ISI Group" Initiated at Buy and Held Target at $45 on, Thursday, March 25th, 2021
